MIDDLE EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS (CoV)

1784 Words4 Pages

Introduction
One of the families of ssRNA viruses which cause upper respiratory tract diseases in humans and birds is the Coronaviridae family. Although the coronaviruses are known since the early 60s (229 and OC43 viruses), they started attracting attention only since 2003, when a virus causing a severe acute respiratory syndrome (SARS) was discovered in an outbreak that took place in southern China and then spread into several countries.1 Ten years after this event, which was responsible of 774 deaths in over 30 countries (of 8000 confirmed cases), a new “SARS-like” infection emerged from the Middle East and was named as Middle East respiratory syndrome coronavirus (MERS-CoV) by the Coronavirus Study Group of the International Committee for Taxonomy of Viruses. Samples taken from two patients with severe cases of community-acquired pneumonia (Bisha, KSA and Doha, Qatar) contributed to the first isolation of the new virus and its sequencing.2 The novel virus was isolated several other times from locals and tourists of the Arabian Peninsula presenting symptoms which resembled those of the first documented victims of the disease. In retrospect, a group of respiratory infections which took place earlier in Jordan (April 2012) was related to this viral agent.3
The genome analysis of MERS-CoV classified the emerging virus as a member of the lineage C of the genus Betacoronavirus. Interestingly, its closest known relatives are present in bats (HkU-4 and HkU-5). In contrast, it is more distantly related to the SARS-CoV not only genetically, but also in means of the virus receptor usage.3

Virion structure and composition
All coronaviruses have four structural proteins in common (Figure 1): a large surface glycoprotein (S; 1150–1450 ami...

... middle of paper ...

...Lancet Infect. Dis. 9, 291–300 (2009).
10. WHO | MERS-CoV summary updates. WHO at
11. CDC - Coronavirus - Middle East Respiratory Syndrome - MERS-CoV. at
12. Zhou, N., Zhang, Y., Zhang, J.-C., Feng, L. & Bao, J.-K. The receptor binding domain of MERS-CoV: The dawn of vaccine and treatment development. J. Formos. Med. Assoc. 113, 143–147 (2014).
13. Watson, J. T., Hall, A. J., Erdman, D. D., Swerdlow, D. L. & Gerber, S. I. Unraveling the Mysteries of Middle East Respiratory Syndrome Coronavirus. Emerg. Infect. Dis. 20, 1054–1056 (2014).
14. Cavanagh, D. in Princ. Pract. Clin. Virol. (Microbiology, A. J. Z. of M., Virology, J. E. B. E. of C., Pattison, J. R., Virology, P. D. G. of & Director, B. D. S. E.) 379–397 (John Wiley & Sons, Ltd, 2004).

More about MIDDLE EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS (CoV)

Open Document